These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9591584)

  • 21. Equal induction and persistence of chromosome aberrations involving chromosomes 1, 4 and 10 in thyroid cancer patients treated with radioactive iodine.
    Puerto S; Marcos R; Ramírez MJ; Galofré P; Creus A; Surrallés J
    Mutat Res; 2000 Aug; 469(1):147-58. PubMed ID: 10946251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive response in patients treated with 131I.
    Monsieurs MA; Thierens HM; Vral AM; Van De Wiele C; De Ridder LI; Dierckx RA
    J Nucl Med; 2000 Jan; 41(1):17-22. PubMed ID: 10647600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
    Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
    J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosome aberrations after high-dose 131I and 99mTc-MIBI administration using a micronucleus assay.
    Asli IN; Mosaffa N; Mogharrabi M; Hooman A; Tabei F; Javadi H; Shafei B; Seyedabadi M; Assadi M
    Nucl Med Commun; 2010 Apr; 31(4):307-10. PubMed ID: 20072074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
    Pahlka RB; Sonnad JR
    Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR.
    Juweid ME; Hajjar G; Stein R; Sharkey RM; Herskovic T; Swayne LC; Suleiman S; Pereira M; Rubin AD; Goldenberg DM
    J Nucl Med; 2000 Jan; 41(1):93-103. PubMed ID: 10647610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital discharge of patients with thyroid carcinoma treated with 131I.
    Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
    J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes.
    Watanabe N; Kanegane H; Kinuya S; Shuke N; Yokoyama K; Kato H; Tomizawa G; Shimizu M; Funada H; Seto H
    J Nucl Med; 2004 Apr; 45(4):608-11. PubMed ID: 15073256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure.
    Modarresifar H; Almodovar S; Bass WB; Ojha B
    Health Phys; 2007 Feb; 92(2 Suppl):S45-9. PubMed ID: 17228187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of chromosome aberrations by FISH and Giemsa assays in lymphocytes of cancer patients undergoing whole-body irradiation: comparison of in vivo and in vitro irradiation.
    Vorobtsova I; Darroudi F; Semyonov A; Kanayeva A; Timofeyeva N; Yakovleva T; Zharinov G; Natarajan AT
    Int J Radiat Biol; 2001 Nov; 77(11):1123-31. PubMed ID: 11683983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
    Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
    Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
    Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premature chromosome condensation associated with fluorescence in situ hybridisation detects cytogenetic abnormalities after a CT scan: evaluaton of the low-dose effect.
    M'kacher R; Violot D; Aubert B; Girinsky T; Dossou J; Béron-Gaillard N; Carde P; Parmentier C
    Radiat Prot Dosimetry; 2003; 103(1):35-40. PubMed ID: 12596987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation dose to the upper spine from therapeutic administrations of iodine-131-sodium iodide.
    Stabin MG
    J Nucl Med; 1993 Apr; 34(4):695-6. PubMed ID: 8455090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients.
    Violot D; M'Kacher R; Adjadj E; Dossou J; de Vathaire F; Parmentier C
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):174-9. PubMed ID: 15449047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Micronuclei and 3AB-index in patients receiving iodine-131 therapy.
    Catena C; Villani P; Nastasi R; Conti D; Righi E; Salerno G; Righi VA; Ronga G
    J Nucl Biol Med (1991); 1994 Dec; 38(4):586-93. PubMed ID: 7786922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation dose assessments in radioiodine (131I) therapy. 1. The necessity for in vivo quantitation and dosimetry in the treatment of carcinoma of the thyroid.
    Schlesinger T; Flower MA; McCready VR
    Radiother Oncol; 1989 Jan; 14(1):35-41. PubMed ID: 2928556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Validation of biological dosimetry in patients conditioned with total body irradiation: conventional cytogenetics and in situ hybridization(FISH)].
    Dossou J; M'kacher R; Bridier A; Girinsky T; Violot D; Légal JD; Lartigau E; Eschwège F; Parmentier C
    Cancer Radiother; 2000; 4(6):399-407. PubMed ID: 11191845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.